IN2014DN06121A - - Google Patents
Info
- Publication number
- IN2014DN06121A IN2014DN06121A IN6121DEN2014A IN2014DN06121A IN 2014DN06121 A IN2014DN06121 A IN 2014DN06121A IN 6121DEN2014 A IN6121DEN2014 A IN 6121DEN2014A IN 2014DN06121 A IN2014DN06121 A IN 2014DN06121A
- Authority
- IN
- India
- Prior art keywords
- ethyleneimine
- oligomer
- concentration
- aqueous solution
- range
- Prior art date
Links
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Peptides Or Proteins (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261592323P | 2012-01-30 | 2012-01-30 | |
| PCT/GB2013/050211 WO2013114112A2 (en) | 2012-01-30 | 2013-01-30 | Stabilized aqueous antibody compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN06121A true IN2014DN06121A (enExample) | 2015-08-14 |
Family
ID=47681959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6121DEN2014 IN2014DN06121A (enExample) | 2012-01-30 | 2013-01-30 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10532098B2 (enExample) |
| EP (1) | EP2809350B1 (enExample) |
| JP (1) | JP2015506369A (enExample) |
| CN (1) | CN104203282A (enExample) |
| CA (1) | CA2861402C (enExample) |
| DK (1) | DK2809350T3 (enExample) |
| ES (1) | ES2705538T3 (enExample) |
| IN (1) | IN2014DN06121A (enExample) |
| WO (1) | WO2013114112A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2705538T3 (es) | 2012-01-30 | 2019-03-25 | Arecor Ltd | Composiciones acuosas de anticuerpo estabilizadas |
| MX2018009967A (es) * | 2016-02-19 | 2018-11-09 | Avery Dennison Corp | Metodos en dos etapas para procesar adhesivos y composiciones relacionadas. |
| GB201613896D0 (en) | 2016-08-12 | 2016-09-28 | Arecor Ltd | Novel composition |
| US11608357B2 (en) | 2018-08-28 | 2023-03-21 | Arecor Limited | Stabilized antibody protein solutions |
| EP3372241A1 (en) | 2017-03-06 | 2018-09-12 | Ares Trading S.A. | Liquid pharmaceutical composition |
| EP3372242A1 (en) | 2017-03-06 | 2018-09-12 | Ares Trading S.A. | Liquid pharmaceutical composition |
| WO2020055679A2 (en) * | 2018-09-10 | 2020-03-19 | Dow Global Technologies Llc | A composition comprising a protein and a polyalkoxy fatty acyl surfactant |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
| US5990237A (en) | 1997-05-21 | 1999-11-23 | Shearwater Polymers, Inc. | Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines |
| DE19726186A1 (de) | 1997-06-20 | 1998-12-24 | Boehringer Ingelheim Int | Komplexe für den Transport von Nukleinsäure in höhere eukaryotische Zellen |
| DE19933024C2 (de) | 1999-07-15 | 2003-03-13 | Medinnova Ges Med Innovationen | Kationische Blockcopolymere |
| US6652886B2 (en) | 2001-02-16 | 2003-11-25 | Expression Genetics | Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents |
| US7524938B2 (en) * | 2003-04-04 | 2009-04-28 | Yeda Research And Development Co., Ltd. | Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| CA2536120A1 (en) | 2003-06-30 | 2005-02-10 | Canji, Inc. | Polymer encapsulation of adenoviruses |
| US7022214B2 (en) | 2004-01-21 | 2006-04-04 | Bio-Rad Laboratories, Inc. | Carrier ampholytes of high pH range |
| TW200719913A (en) * | 2005-03-08 | 2007-06-01 | Pharmacia & Upjohn Co Llc | Anti-madcam antibody compositions |
| US20090011004A1 (en) | 2005-12-30 | 2009-01-08 | Philadelphia Health & Education Corp., D/B/A/ Drexel University Of College Of Medicine | Improved carriers for delivery of nucleic acid agents to cells and tissues |
| GB0700523D0 (en) | 2007-01-11 | 2007-02-21 | Insense Ltd | The Stabilisation Of Proteins |
| US20080312174A1 (en) | 2007-06-05 | 2008-12-18 | Nitto Denko Corporation | Water soluble crosslinked polymers |
| CA2737407A1 (en) | 2008-09-24 | 2010-04-01 | Stabilitech Ltd. | Method for preserving polypeptides using a sugar and polyethyleneimine |
| AU2009319856A1 (en) * | 2008-11-28 | 2010-06-03 | Abbvie Inc. | Stable antibody compositions and methods for stabilizing same |
| RU2600847C2 (ru) * | 2010-05-10 | 2016-10-27 | Интас Биофармасьютикалс Лимитед | Жидкий состав полипептидов, содержащих fc-домен иммуноглобулина |
| US20130209465A1 (en) * | 2010-07-30 | 2013-08-15 | Arecor Ltd. | Stabilized Aqueous Antibody Compositions |
| ES2705538T3 (es) | 2012-01-30 | 2019-03-25 | Arecor Ltd | Composiciones acuosas de anticuerpo estabilizadas |
-
2013
- 2013-01-30 ES ES13703468T patent/ES2705538T3/es active Active
- 2013-01-30 DK DK13703468.2T patent/DK2809350T3/en active
- 2013-01-30 US US14/375,257 patent/US10532098B2/en active Active
- 2013-01-30 CA CA2861402A patent/CA2861402C/en active Active
- 2013-01-30 JP JP2014553812A patent/JP2015506369A/ja active Pending
- 2013-01-30 WO PCT/GB2013/050211 patent/WO2013114112A2/en not_active Ceased
- 2013-01-30 IN IN6121DEN2014 patent/IN2014DN06121A/en unknown
- 2013-01-30 EP EP13703468.2A patent/EP2809350B1/en active Active
- 2013-01-30 CN CN201380017932.0A patent/CN104203282A/zh active Pending
-
2019
- 2019-11-27 US US16/697,999 patent/US12016922B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US12016922B2 (en) | 2024-06-25 |
| EP2809350B1 (en) | 2018-10-17 |
| CA2861402C (en) | 2021-10-12 |
| US20200138946A1 (en) | 2020-05-07 |
| US10532098B2 (en) | 2020-01-14 |
| CA2861402A1 (en) | 2013-08-08 |
| CN104203282A (zh) | 2014-12-10 |
| US20150010548A1 (en) | 2015-01-08 |
| EP2809350A2 (en) | 2014-12-10 |
| JP2015506369A (ja) | 2015-03-02 |
| WO2013114112A2 (en) | 2013-08-08 |
| WO2013114112A3 (en) | 2013-11-07 |
| ES2705538T3 (es) | 2019-03-25 |
| DK2809350T3 (en) | 2019-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN06121A (enExample) | ||
| NZ743964A (en) | Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab | |
| EA201890006A1 (ru) | Применение экзосом для лечения болезни | |
| EA201590388A1 (ru) | Способы лечения таупатии | |
| MX369106B (es) | Anticuerpo anti trop-2 humano que tiene actividad anti-tumoral in vivo. | |
| EA201500314A1 (ru) | Лекарственные формы энзалутамида | |
| EA201790378A1 (ru) | Заключенное в липосому аффинное лекарственное средство | |
| EA201491447A1 (ru) | Ендиины, их конъюгаты и способы их получения и применения | |
| EA201590174A1 (ru) | Иммуноконъюгаты, содержащие анти-cd22 антитела | |
| EA201300987A1 (ru) | Фармацевтические композиции, включающие метформин и ингибитор dpp-4 или ингибитор sglt-2 | |
| MY160552A (en) | Low protein infant formula with increased essential amino acids | |
| AU345145S (en) | Bottle | |
| UA110103C2 (uk) | Модифікований туберкульозний антиген | |
| MX2016008448A (es) | Conjugados de var2csa-farmaco. | |
| AU344326S (en) | Bottle | |
| AU337524S (en) | Bottle | |
| MY173304A (en) | Induction of immune tolerance using methotrexate | |
| GB2496342A (en) | Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia | |
| AU345141S (en) | Bottle | |
| EA201590061A1 (ru) | Фармацевтическая композиция | |
| EA201401117A1 (ru) | Композиции, содержащие пробиотики и комплекс пчелиной пыльцы/глины, способ их приготовления и их применение в питании и терапии | |
| AU343226S (en) | Bottle | |
| CY1118277T1 (el) | Σταθερη φαρμακοτεχνικη μορφη πεξιγανανης | |
| GT201300058A (es) | Composiciones de anticuerpos anti-vegfr-3 | |
| EA201400444A1 (ru) | Производные 2-оксопиперидинила |